Christopher Scott Hill - Dec 31, 2021 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role: SVP & CFO
Signature: /s/ Mark Tattoli, Attorney-in-Fact
Stock symbol: CLB
Transactions as of: Dec 31, 2021
Transactions value $: -$206,568
Form type: 4
Date filed: 1/4/2022, 04:55 PM
Next filing: Feb 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	CLB	Common Shares	Tax liability	-$207K	-9.26K	-23.02%	$22.31^*	31K	Dec 31, 2021	Direct
transaction	CLB	Common Shares	Options Exercise	$0	+23.5K	+141.03%	$0.00	40.2K	Dec 31, 2021	Direct
holding	CLB	Common Shares						59	Dec 31, 2021	401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Performance Shares	Options Exercise	$0	-23.5K	-100%	$0.00^*	0	Dec 31, 2021	Common Shares	23.5K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares vesting were awarded as restricted performance shares in February 2019 as reported in the Form 4 filing on February 14, 2019. This filing states that 50% of the restricted performance shares will vest at the end of the Performance Period if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th ROIC percentile of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG. The Company was the top performing ROIC company as of the end of the performance period and as such the performance criteria and all requirements for full vesting have been met and thus the shares granted in February 2019 vested on December 31, 2021, at the conclusion of the performance period.

Content

The shares vesting were awarded as restricted performance shares in February 2019 as reported in the Form 4 filing on February 14, 2019. This filing states that 50% of the restricted performance shares will vest at the end of the Performance Period if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th ROIC percentile of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG. The Company was the top performing ROIC company as of the end of the performance period and as such the performance criteria and all requirements for full vesting have been met and thus the shares granted in February 2019 vested on December 31, 2021, at the conclusion of the performance period.